entertainment -WSS

entertainment

author：knowledge 2025-08-11 09:47:47 - browse：8

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： How Medicaid coverage policies for immigrants impact new moms

knowledge

WSS

Startup Neumora takes a novel depression drug to Phase 3

Streamlined flu vaccines recommended by FDA advisory panel

IVF doctors demand details after CooperSurgical lawsuit

For AI in health care standards, federal regulators join with industry group

State of the Union pitch: Bigger Medicare drug price negotiations

IVF doctors demand details after CooperSurgical lawsuit

focus

entertainment

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Psychedelics group wrestles with new pharma identity

How Medicaid coverage policies for immigrants impact new moms

Cancer drug shortages should be causing more outrage

Medicare has a new plan to address drug shortages

Psychedelics group wrestles with new pharma identity

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

United colonoscopy coverage change 'may cost lives,' doctors say

How dance can help nurses traumatized by Covid

hotspot

STAT Virtual Event: The State of Biosimilars: What to Watch

How Medicaid coverage policies for immigrants impact new moms

Longer MASH drug regimen improved liver, Akero study finds

Google and Epic fight stronger regulation of AI in health care

Cosmetics set for new safety regulation. Why the industry is on board

Microsoft's Peter Lee: Generative AI could help doctors be more human

explore

Wikipedia

knowledge

Wikipedia